CAPTRUST Financial Advisors
PASG icon

CAPTRUST Financial Advisors’s Passage Bio PASG Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32
Closed -$2K – 3428
2022
Q2 		$2K Hold
32
– – ﹤0.01% 4497
2022
Q1 		$2K Hold
32
– – ﹤0.01% 4521
2021
Q4 		$4K Hold
32
– – ﹤0.01% 4182
2021
Q3 		$6K Hold
32
– – ﹤0.01% 3881
2021
Q2 		$9K Buy
32
+7
+28% +$2.17K ﹤0.01% 3608
2021
Q1 		$9K Buy
25
+11
+79% +$4.7K ﹤0.01% 3493
2020
Q4 		$7K Buy
+14
New +$5.61K ﹤0.01% 2709

Other funds holding PASG

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

CAPTRUST Financial Advisors's PASG Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Passage Bio (PASG) in Q3 2022, closing a stake of 32 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in PASG in Q4 2020 and held it in 7 quarters. The position peaked at $9K in Q2 2021. 75 funds tracked by Wall St. Rank hold PASG as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Passage Bio position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 32 Passage Bio shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Passage Bio in Q4 2020 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Passage Bio position peaked at $9K in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Passage Bio as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.